Tag: Greater Than

People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more...

Adults with type 2 diabetes on semaglutide 1 mg whose dose was increased to 2 mg were as likely to reach an HbA1c level...

First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control

Phase 2 Study Results Highlight Use of Once-Daily Injection for Weight Loss and Reduction in Insulin UseNEW ORLEANS, June 5, 2026 /PRNewswire/ -- A...

S&P Dow Jones Indices Consultation on Treatment of MegaCap Companies – Results

NEW YORK, June 4, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") conducted a consultation with market participants on potential changes to the S&P U.S....

Coast Copper Announces Warrant Acceleration

/THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/TSX.V: COCOVANCOUVER, BC, June 4, 2026 /CNW/...

Rock Chips Just Hit 100 g/t Gold Next to a BHP-Drilled Copper System

Issued on behalf of Salazar Resources Limited (TSXV: SRL)VANCOUVER, BC, June 3, 2026 /PRNewswire/ -- USA News Group News Commentary — In mineral exploration, two...

Colliers releases 2025 Global Sustainability Report

Highlights emissions reductions and progress in delivering long-term value

Highlights emissions reductions and progress in delivering long-term value

Manufacturing PMI® at 54%; May 2026 ISM® Manufacturing PMI® Report

New Orders Growing; Production Growing; Employment Contracting; Supplier Deliveries Slowing; Raw Materials Inventories Contracting; Customers' Inventories Too Low; Prices Increasing; Imports Growing; Exports GrowingTEMPE,...

Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis

PAPZIMEOS approval marks a historic milestone for the RRP patient community as the first and only FDA-approved therapy for the treatment of adults with...

TowneBank and Old Point Financial Corporation Announce Expected Closing Date and Election Deadline for Merger

SUFFOLK, Va. and HAMPTON, Va., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Hampton Roads based TowneBank (NASDAQ: TOWN) and Old Point Financial Corporation (NASDAQCM: OPOF) (“Old Point”), the parent company of The Old Point National Bank of Phoebus (“Old Point National Bank”), today announced that they had received regulatory approval from the Federal Deposit Insurance Corporation (the “FDIC”) and the Bureau of Financial Institutions of the Virginia State Corporation Commission to complete the proposed merger of Old Point and Old Point National Bank with TowneBank. All regulatory approvals required for the transaction have now been received. The merger is expected to close on or about September 1, 2025, subject to the satisfaction of customary closing conditions.

Akero Therapeutics Announces Lancet Publication of the Phase 2b HARMONY Clinical Trial Demonstrating 96 Weeks Treatment with EFX Reduced Liver Fibrosis in Patients with...

Results support potential of efruxifermin (EFX) to reduce risk of fibrosis progression in patients with pre-cirrhotic (F2-F3) MASH

Results support potential of efruxifermin (EFX) to reduce risk of fibrosis progression in patients with pre-cirrhotic (F2-F3) MASH

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsGreater Than

Lennox-Gastaut Syndrome (LGS) Foundation Launches Pre-Competitive Research Accelerator for LGS and Associated Developmental and Epileptic Encephalopathies

J.S. Held Earns Multiple Rankings in Inaugural Legal 500 Disputes Services Guide

EPAM and TGS Announce Strategic Collaboration to Accelerate AI Adoption at Scale in Energy Sector

Tag: Greater Than

People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more...

First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control

S&P Dow Jones Indices Consultation on Treatment of MegaCap Companies – Results

Coast Copper Announces Warrant Acceleration

Rock Chips Just Hit 100 g/t Gold Next to a BHP-Drilled Copper System

Colliers releases 2025 Global Sustainability Report

Manufacturing PMI® at 54%; May 2026 ISM® Manufacturing PMI® Report

Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis

TowneBank and Old Point Financial Corporation Announce Expected Closing Date and Election Deadline for Merger

Akero Therapeutics Announces Lancet Publication of the Phase 2b HARMONY Clinical Trial Demonstrating 96 Weeks Treatment with EFX Reduced Liver Fibrosis in Patients with...

TowneBank and Old Point Financial Corporation Announce Expected Closing Date and Election Deadline for Merger

Biotech Stocks Rally as Oncology Market Targets $866B by 2034

Peace One Day Transforms Peace Day, 21 September 2025 into the World’s Largest Online Festival for Peace

Simon Property Group Sells $1.5 Billion of Senior Notes

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us